Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4636611

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C=CC(=O)N1CCN(c2nc(OC[C@@H]3CCCN3C)nc3c2CCN(c2cccc4cccc(C(F)(F)F)c24)C3)C[C@@H]1CC#N

Basic Information

ChEMBL ID CHEMBL4636611
Phase Preclinical
Structure Type MOL
InChI Key FWHBOKRDXHCGNI-ZEQRLZLVSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names

Molecular Properties

619.7
MW (Da)
4.80
ALogP
8
HBA
0
HBD
88.8
PSA (Ų)
0.35
QED
1
Ro5 Violations
7
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C33H36F3N7O2
MW 619.69
Aromatic Rings 3
Heavy Atoms 45
NP-Likeness -0.68

Activity Summary

IC50 1 meas. best 8.4

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
GTPase KRas
CHEMBL2189121
IC50 8.4 8.4 4.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
GTPase KRas IC50 = 4.0 nM 8.4 Inhibition of KRAS G12C mutant in human NCI-H358 cells assessed as reduction in ... 32250617

Literature References

PubMed DOI Target Context # Activities
32250617 10.1021/acs.jmedchem.9b02052 GTPase KRas 1

Data from ChEMBL 36 via Core Engine